Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Business Update
GlaxoSmithKline acquires vaccine plant in the U.S.
September 29th, 2005
GlaxoSmithKline (GSK) announced that it is expanding its ability to increase vaccines supplies for Americans by acquiring a vaccine research and production facility in Marietta, Pennsylvania. This acquisition adds to the company's growing vaccines presence in the United States, following GSK's recent purchase of Corixa Corp., a developer of vaccine adjuvants that the company says increase immune response. "GlaxoSmithKline can help boost the availability of vaccines for Americans in the future by growing our research and manufacturing capacity in Pennsylvania and the United States today," said JP Garnier, CEO of GlaxoSmithKline. "We are working...
Source: Women's Health Weekly (2005-09-29)
|
